Efficiency of Treatment for Recurrent Afthous Stomatitis of the Oropharyngial Region in Patients with Chronic Cholecystitis
|
|
Author:
|
KAMILOV HAYDAR POZILOVICH, IBRAGIMOVA MALIKA KHUDAYBERGANOVNA, UBAYDULLAEVA NIGORA ILYASOVNA
|
Abstract:
|
Chronic recurrent aphthous stomatitis (CRAS) is a chronic inflammatory disease of the oral mucosa and
characterized by the appearance of aphthous ulcers with a long course and periodic remissions and
exacerbations. Much attention is paid to somatic diseases, which aggravate the course of CRAS. V.A. Epishev
observed chronic recurrent aphthous stomatitis in gastrointestinal diseases in 15.2% of cases, according to G.V.
Banchenko - 12%.
The factors provoking relapses include microorganisms that in the process of vital activity, especially during
death, release bacterial endotoxins, which have both antigenic and toxic features. An increased process of tissue
alteration during the activation of catabolic processes is one of the causes of endogenous intoxication
(Sidelnikova V.I., Chernitskiy A.E., Retsky M.I., 2015). In chronic cholecystitis, CRAS is often observed in the
oropharyngeal region. The drug Baktizidime was introduced as the treatment regimen of CRAS of the
oropharyngial region of the main group and the drug Eludril into the comparison group.
|
Keyword:
|
CRAS, oropharyngeal region, aphthae, ulcers, chronic cholecystitis, Baktizidim
|
EOI:
|
-
|
DOI:
|
https://doi.org/10.31838/ijpr/2021.13.03.017
|
Download:
|
Request For Article
|
|
|